Cholesterol Lowering for Type 1 Diabetes

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

Recruiting Phase 4 Interventional Study
Type 1 Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 89
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Other
Participants needed
125 (estimated)
Sponsor
NYU Langone Health · Other
Who this trial is looking for

This trial is looking for adults with Type 1 Diabetes who want to help researchers study how lowering cholesterol affects various health factors. Participants will be followed for one to two months to gather information.

Are You a Good Fit for This Trial?
Rules you out Established cardiovascular diseaseChronic kidney diseaseType 2 diabetes

You may be able to join if

  • I have Type 1 Diabetes diagnosed for at least 1 year.
  • I am between 18 and 90 years old.
  • My LDL cholesterol is greater than 100 mg/dl.
  • I can provide signed consent to participate.

You may not be able to join if

  • I have heart disease and use blood-thinning medication.
  • My triglycerides are greater than 400 mg/dl.
  • I have had an infection in the past 30 days.
  • I have been hospitalized in the past 30 days.
  • I am currently pregnant.
  • I have a severe kidney condition.
  • I have anemia or abnormal platelet counts.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This is a prospective, interventional, cohort study, meaning that researchers will follow and observe a group of enrolled study participants over a period of time (one to two months) to gather information and record any developments of the outcomes in question. This study will recruit 125 participants with Type 1 Diabetes (T1D) to: 1. Analyze the effect of reducing the cholesterol levels in the …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Participants with previous diagnosis of T1D (as defined by American Diabetes Association or judgment of physician for at least 1 year) 1. American Diabetes Association Criteria for diagnosis of diabetes (Must meet at least 1 of the following criteria): * i. FPG ≥12…
Contacts

Ira Goldberg, MD

646-501-0589

Ira.Goldberg@nyulangone.org

CONTACT